Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Absci (ABSI) Shares Outstanding (Weighted Average) (2020 - 2025)

Absci's Shares Outstanding (Weighted Average) history spans 6 years, with the latest figure at $132.1 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 16.28% year-over-year to $132.1 million; the TTM value through Sep 2025 reached $132.1 million, up 16.28%, while the annual FY2024 figure was $110.2 million, 19.79% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $132.1 million at Absci, up from $126.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $132.1 million in Q3 2025 and bottomed at $17.0 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $91.8 million (2023), against an average of $89.8 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) soared 431.64% in 2022 before it grew 1.3% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $49.7 million in 2021, then soared by 82.84% to $90.8 million in 2022, then rose by 1.3% to $92.0 million in 2023, then grew by 19.79% to $110.2 million in 2024, then rose by 19.84% to $132.1 million in 2025.
  • Per Business Quant, the three most recent readings for ABSI's Shares Outstanding (Weighted Average) are $132.1 million (Q3 2025), $126.0 million (Q2 2025), and $124.5 million (Q1 2025).